Status:
TERMINATED
Patient Rheumatoid Arthritis Social Support Study
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Amgen
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of PARASS is to develop a network of increased social support for Rheumatoid Arthritis (RA) patients that will improve patient outcomes and further promote understanding of RA among physician...
Detailed Description
Rheumatoid arthritis (RA) is a chronic disabling disease that affects nearly 1% of the U. S. population \[1\]. The illness causes destruction of joint cartilage and erosion of adjacent bone, leading t...
Eligibility Criteria
Inclusion
- billing diagnosis of rheumatoid arthritis (714.0) or seronegative inflammatory arthritis or a member of the BRASS and PACO studies at Brigham and Women's Hospital
Exclusion
- less than 18 years of age
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2019
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT01525654
Start Date
March 1 2009
End Date
March 1 2019
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115